Posted 09 July, 2021
Transcode Therapeutics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:RNAZ in a 424B4 filed on 09 July, 2021.
This is a firm commitment initial public offering of common stock of TransCode Therapeutics, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Transcode Therapeutics, Inc.
Health Care/Life Sciences • Pharmaceuticals
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.Market Cap
$4.60M
View Company Details
$4.60M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.